These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 385880)

  • 1. Anticandidal activity of 5-fluorocytosine-peptide conjugates.
    Steinfeld AS; Naider F; Becker JM
    J Med Chem; 1979 Sep; 22(9):1104-9. PubMed ID: 385880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticandidal activity of pyrimidine-peptide conjugates.
    Ti JS; Steinfeld AS; Naider F; Gulumoglu A; Lewis SV; Becker JM
    J Med Chem; 1980 Aug; 23(8):913-8. PubMed ID: 6995613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae.
    Paluszynski JP; Klassen R; Rohe M; Meinhardt F
    Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH; Andrews FA; Sarosi GA
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of yeast isolates from defined German patient groups to 5-fluorocytosine.
    Weber S; Polak A
    Mycoses; 1992; 35(7-8):163-71. PubMed ID: 1287480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity and resistance of Candida to 5-fluorocytosine. Relationship to the cell wall ultrastructure].
    Montplaisir S; Drouhet E; Nabarra B
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(19):2211-3. PubMed ID: 807407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucytosine analogues obtained through Biginelli reaction as efficient combinative antifungal agents.
    Wani MY; Ahmad A; Kumar S; Sobral AJ
    Microb Pathog; 2017 Apr; 105():57-62. PubMed ID: 28189732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of purines and pyrimidines on the fungistatic activity of 5-fluorocytosine in Aspergillus species.
    Wagner GE; Shadomy S
    Antimicrob Agents Chemother; 1977 Feb; 11(2):229-33. PubMed ID: 848925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.